These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18633156)

  • 1. Characterization of STZ-Induced Type 2 Diabetes in Zucker Fatty Rats.
    Okamoto T; Kanemoto N; Ohbuchi Y; Okano M; Fukui H; Sudo T
    Exp Anim; 2008 Jul; 57(4):335-45. PubMed ID: 18633156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
    Wasan KM; Risovic V; Yuen VG; McNeill JH
    J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Mitiglinide Combined with Dapagliflozin in Streptozotocin-nicotinamide-induced Type 2 Diabetic Rats and in Zucker Fatty Rats.
    Akahane K; Inoue T; Yokoyama A; Yaguchi A; Ojima K; Kiguchi S; Maruyama K; Kobayashi M; Mori Y
    Drug Res (Stuttg); 2015 Aug; 65(8):416-21. PubMed ID: 25188606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective and antidiabetic effects of extract from Nigella sativa on blood glucose concentrations against streptozotocin (STZ)-induced diabetic in rats: an experimental study with histopathological evaluation.
    Alimohammadi S; Hobbenaghi R; Javanbakht J; Kheradmand D; Mortezaee R; Tavakoli M; Khadivar F; Akbari H
    Diagn Pathol; 2013 Aug; 8():137. PubMed ID: 23947821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new animal model of non-insulin-dependent diabetes mellitus with hypertension: neonatal streptozotocin treatment in spontaneously hypertensive rats.
    Iwase M
    Fukuoka Igaku Zasshi; 1991 Jul; 82(7):415-27. PubMed ID: 1833297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet beta cell failure in the 60% pancreatectomised obese hyperlipidaemic Zucker fatty rat: severe dysfunction with altered glycerolipid metabolism without steatosis or a falling beta cell mass.
    Delghingaro-Augusto V; Nolan CJ; Gupta D; Jetton TL; Latour MG; Peshavaria M; Madiraju SR; Joly E; Peyot ML; Prentki M; Leahy J
    Diabetologia; 2009 Jun; 52(6):1122-32. PubMed ID: 19294363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
    Srinivasan K; Viswanad B; Asrat L; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Oct; 52(4):313-20. PubMed ID: 15979893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and pathophysiological characterization of type 2 diabetic mouse model produced by streptozotocin and nicotinamide.
    Nakamura T; Terajima T; Ogata T; Ueno K; Hashimoto N; Ono K; Yano S
    Biol Pharm Bull; 2006 Jun; 29(6):1167-74. PubMed ID: 16755011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
    Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
    Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of insulin resistance in the popularly used four rat models of type-2 diabetes.
    Chao PC; Li Y; Chang CH; Shieh JP; Cheng JT; Cheng KC
    Biomed Pharmacother; 2018 May; 101():155-161. PubMed ID: 29486333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat.
    Pick A; Clark J; Kubstrup C; Levisetti M; Pugh W; Bonner-Weir S; Polonsky KS
    Diabetes; 1998 Mar; 47(3):358-64. PubMed ID: 9519740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an alternative non-obese non-genetic rat model of type 2 diabetes using caffeine and streptozotocin.
    Naidoo P; Islam MS
    Pharmacol Rep; 2014 Aug; 66(4):585-93. PubMed ID: 24948058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rat model of type 2 diabetic mellitus and its glycometabolism characters.
    Zhang F; Ye C; Li G; Ding W; Zhou W; Zhu H; Chen G; Luo T; Guang M; Liu Y; Zhang D; Zheng S; Yang J; Gu Y; Xie X; Luo M
    Exp Anim; 2003 Oct; 52(5):401-7. PubMed ID: 14625406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dosage of streptozocin in inducing rat model of type 2 diabetes mellitus].
    Xiang X; Wang Z; Zhu Y; Bian L; Yang Y
    Wei Sheng Yan Jiu; 2010 Mar; 39(2):138-42. PubMed ID: 20459021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice.
    Wang Z; Gleichmann H
    Diabetes; 1998 Jan; 47(1):50-6. PubMed ID: 9421374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
    Portha B; Serradas P
    Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of type 2 diabetic mellitus animal models via interactions between insulin and mitogen‑activated protein kinase signaling pathways induced by a high fat and sugar diet and streptozotocin.
    Zhuo J; Zeng Q; Cai D; Zeng X; Chen Y; Gan H; Huang X; Yao N; Huang D; Zhang C
    Mol Med Rep; 2018 Apr; 17(4):5132-5142. PubMed ID: 29393432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat.
    Cummings BP; Digitale EK; Stanhope KL; Graham JL; Baskin DG; Reed BJ; Sweet IR; Griffen SC; Havel PJ
    Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1782-93. PubMed ID: 18832086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "2-(4-Fluorobenzamido)-4-methylthiazole-5-carboxylic acid" a novel thiazole compound, ameliorates insulin sensitivity and hyperlipidaemia in streptozotocin-induced diabetic rats: Plausible role of inflammatory and oxidative stress markers.
    Paudel YN; Ali MR; Adil M; Bawa S; Sharma M
    Biomed Pharmacother; 2017 Nov; 95():1232-1241. PubMed ID: 28938514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 4-methyl-2-[(2-methylbenzyl) amino]-1,3-thiazole-5-carboxylic acid against hyperglycemia, insulin sensitivity, and oxidative stress-induced inflammatory responses and β-cell damage in the pancreas of streptozotocin-induced diabetic rats.
    Paudel YN; Ali MR; Bawa S; Shah S; Adil M; Siddiqui A; Basheer AS; Hassan MQ; Sharma M
    Hum Exp Toxicol; 2018 Feb; 37(2):163-174. PubMed ID: 29233026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.